AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Norfolk Southern
NSC
|
+$544M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$383M |
| 3 |
McDonald's
MCD
|
+$351M |
| 4 |
Goldman Sachs
GS
|
+$339M |
| 5 |
Northrop Grumman
NOC
|
+$294M |
Top Sells
| 1 |
US Bancorp
USB
|
+$471M |
| 2 |
Pfizer
PFE
|
+$379M |
| 3 |
Verizon
VZ
|
+$297M |
| 4 |
Bank of America
BAC
|
+$265M |
| 5 |
Exxon Mobil
XOM
|
+$251M |
Sector Composition
| 1 | Technology | 15.89% |
| 2 | Financials | 15.86% |
| 3 | Healthcare | 13.23% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Griffon
GFF
$3.59B
| $1.07M | ﹤0.01% |
43,243
+1,000
| +2% | +$24.7K |
|
2177
National Healthcare
NHC
$1.79B
| $1.07M | ﹤0.01% |
14,936
| – | – |
|
2178
Abercrombie & Fitch
ANF
$4.08B
| $1.06M | ﹤0.01% |
88,990
| – | – |
|
2179
Southside Bancshares
SBSI
$899M
| $1.06M | ﹤0.01% |
32,256
| – | – |
|
|
LDL
2180
DELISTED
Lydall, Inc.
LDL
| $1.06M | ﹤0.01% |
19,700
-1,000
| -5% | -$53.6K |
|
2181
Caesarstone
CSTE
$52.2M
| $1.06M | ﹤0.01% |
29,100
-2,300
| -7% | -$83.4K |
|
|
ZNGA
2182
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.05M | ﹤0.01% |
369,379
-1,718,400
| -82% | -$4.9M |
|
2183
Credit Acceptance
CACC
$5.63B
| $1.05M | ﹤0.01% |
5,269
-30
| -0.6% | -$5.98K |
|
2184
JELD-WEN Holding
JELD
$534M
| $1.05M | ﹤0.01% |
+32,003
| New | +$1.05M |
|
|
HIBB
2185
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.05M | ﹤0.01% |
35,589
| – | – |
|
|
EQM
2186
DELISTED
EQM Midstream Partners, LP
EQM
| $1.04M | ﹤0.01% |
13,553
+3,913
| +41% | +$301K |
|
|
BNFT
2187
DELISTED
Benefitfocus, Inc.
BNFT
| $1.03M | ﹤0.01% |
37,010
+17,910
| +94% | +$500K |
|
2188
CTS Corp
CTS
$1.23B
| $1.03M | ﹤0.01% |
48,400
| – | – |
|
|
CS
2189
DELISTED
Credit Suisse Group
CS
| $1.03M | ﹤0.01% |
+69,162
| New | +$1.03M |
|
2190
HEICO
HEI
$44.9B
| $1.02M | ﹤0.01% |
28,584
-4,272
| -13% | -$153K |
|
2191
QuidelOrtho
QDEL
$2.01B
| $1.02M | ﹤0.01% |
45,049
-1,600
| -3% | -$36.2K |
|
|
LHCG
2192
DELISTED
LHC Group LLC
LHCG
| $1.02M | ﹤0.01% |
18,924
-1,200
| -6% | -$64.7K |
|
2193
Middlesex Water
MSEX
$935M
| $1.02M | ﹤0.01% |
27,520
+51
| +0.2% | +$1.89K |
|
|
ORIT
2194
DELISTED
Oritani Financial Corp. New
ORIT
| $1.02M | ﹤0.01% |
59,714
-1,400
| -2% | -$23.8K |
|
2195
ATN International
ATNI
$235M
| $1.01M | ﹤0.01% |
14,370
| – | – |
|
2196
Esperion Therapeutics
ESPR
$558M
| $1.01M | ﹤0.01% |
28,570
-2,700
| -9% | -$95.4K |
|
|
ICPT
2197
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.01M | ﹤0.01% |
8,909
-30
| -0.3% | -$3.39K |
|
|
NE
2198
DELISTED
Noble Corporation
NE
| $1.01M | ﹤0.01% |
162,783
-5,940
| -4% | -$36.8K |
|
|
ARAV
2199
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.01M | ﹤0.01% |
7,855
+5,588
| +246% | +$716K |
|
|
ESND
2200
DELISTED
Essendant Inc.
ESND
| $1.01M | ﹤0.01% |
66,398
-222
| -0.3% | -$3.36K |
|